Treatment of pityriasis rosea, a skin rash, with antiviral drug acyclovir
Phase 3
Completed
- Conditions
- Health Condition 1: null- Pityriasis rosea
- Registration Number
- CTRI/2012/09/002995
- Lead Sponsor
- KLM Laboratories Pvt Ltd Provided acyclovir tablets and placebo tablets only
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
(a) Fulfillment of diagnostic criteria (Chuh 2003).
(b) Informed consent given by the patient
(c) Weight 40 kg or more
Exclusion Criteria
(a) Pregnancy
(b) Lactation
(c) Inability to come for weekly follow up visits
(d) Any treatment in past one week
(e) Any other illness as revealed by history
(f) History of renal disease
(g) History of drug reaction to acyclovir
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disappearance of skin lesions except post-inflammatory changes.Timepoint: Patients will be examined weekly.
- Secondary Outcome Measures
Name Time Method 50% reduction in severity.Timepoint: Patients will be examined weekly.